In that Lily article it states that it was used in M/M and that 1% of treated patients were hospitalized and 5% of placebo were hospitalized.
In the slide released by CYDY at the Annual meeting, their M/M trial, they had 1.7% hospitalized and 10.7% placebo. An 20% reduction as apposed to a 85% reduction.